4XWA

TMK from S.aureus in complex with the Piperidinyl Thymine class inhibitor with a C5 ethyl-amine

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	ROTATING ANODE
Source details	RIGAKU FR-E+ SUPERBRIGHT
Temperature [K]	100
Detector technology	CCD
Collection date	2011-06-06
Detector	RIGAKU SATURN 944+
Wavelength(s)	1.54
Spacegroup name	P 1 21 1
Unit cell lengths	45.483, 89.806, 50.875
Unit cell angles	90.00, 99.29, 90.00

Refinement procedure

Resolution	33.830 - 1.890
R-factor	0.1944
Rwork	0.193
R-free	0.22910
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	apo-state structure
RMSD bond length	0.010
RMSD bond angle	1.060
Data reduction software	XDS (3.3.15)
Data scaling software	SCALA
Phasing software	AMoRE
Refinement software	BUSTER (2.11.6)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	33.831	33.831	1.990
High resolution limit [Å]	1.887	5.970	1.890
Rmerge		0.018	0.212
Rmeas	0.053
Rpim	0.029	0.014	0.204
Total number of observations	88375	3212	7556
Number of reflections	31072
<I/σ(I)>	16.2	38.8	3.6
Completeness [%]	95.9	98	84.4
Redundancy	2.8	3.1	1.9

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7	293	To obtain the inhibitor bound crystal form of TMK-S.aureus crystals were initially grown in the absence of compound using the sitting drop method at 293 K with a reservoir solution of 100 mM PCPT (propionate-cacodylate-bistris propane buffer) pH 7-8, 21-24% PEG 3350, 200 mM Mg2Cl using 1:1 protein:reservoir solution with the protein solution at 13 mg/mL. Crystals were harvested and soaked overnight in a solution containing 100 mM PCPT, 35% PEG 3350, 200 mM Mg2Cl and 1-2 mM TK-666 from a 100 mM DMSO stock. After soaking the crystals were cryoprotected by soaking for 15 minutes in compound-soak solution supplemented with 20% ethylene glycol. Cryoprotected crystals were mounted on nylon loops and flash-cooled in liquid nitrogen.